Oral cancer
Conditions
Interventions
None listed
Sponsors
Nagasaki University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The subjects must meet all the following criteria. 1. Malignant tumors originated from the oral cavity. 2. Confirmed that a histopathological malignant. 3. In locally advanced cases, the cases in UICC 7th edition stage III / IV, or recurrent and/or metastatic cases with not indicated for local therapy. 4. Received any of the therapies described below. i) Radiation therapy (at least 60Gy) ii) Some chemotherapy 5. Age at the time of registration at least 20 years of age 6. Performance status: 0-2 7. December 21, 2012 or later, the case that the treatment of cetuximab has been started.
Exclusion criteria
Exclusion criteria: Patients also applicable in one of the following are excluded as a target. 1. Cases with cetuximab treatment to December 20, 2012 or earlier. 2. Cases with complications in life prognosis in addition to oral cancer. 3. Cases with active double cancer. However, gastric cancer was cured by carcinoma in situ, or endoscopic mucosal resection that is judged to be cured with local treatment, esophageal cancer, colorectal cancer, such as pM it is not included in the activities of the overlapping cancer. 4. Other, patients principal investigator has determined to be inappropriate as a subject.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse events, 1-year progression-free survival and 1-year survival rate. | — |
Countries
Japan
Contacts
Public ContactSouichi Yanamoto
Nagasaki University Hospital, Dentistry for Medically Compromised Patient
Outcome results
None listed